Image Credit: Eater
Every week we track the business, tech and investment trends in CPG, retail, restaurants, agriculture, cooking and health, so you don’t have to. Here are some of this week’s top headlines.
Foxtrot is set for a revival with plans to reopen 15 stores across Chicago, Dallas, and Austin this summer, while Meati Foods, known for its mycelium-based cutlets and steaks, secures $100M in funding despite recent layoffs, expanding to 7,000 retail locations.
In other news, we’ve wrapped the first season of our podcast in partnership with AgFunder: New Food Order, a nuanced investigation into the business of tackling our climate and social crises through food and agriculture. Read all about why we launched the podcast, and be sure to subscribe and share!
Our newsletter takes a lot of time and resources to produce. Make a one time or monthly contribution to help us keep it going. Whether it’s $5 or $500, every bit helps and shows us that you value our work.
Co-founder Mike LaVitola announced plans to reopen 15 stores in Chicago, Dallas, and Austin, Texas, this summer.
The company makes cutlets and steaks from mycelium. The new funding comes three months after it laid off 13% of its employees.
Bioreactor supplier ABEC has accused Eat Just and its cultivated meat subsidiary GOOD Meat of engaging in “the worst aspects of litigation practice in the profession” in a May 30 court filing.
Evaluating radical new solutions based on whether they scale can be directly at odds with the very nature of these solutions.
The breakthrough marks the first time seedlessness has been accomplished in any caneberry variety, potentially transforming the blackberry market and paving the way for advancements in other fruits.
A noissue and Snaxshot collaboration where you can find all the details about brands and products that are new, unique, and out of this world! In our first issue, we look at restaurant brands that have successfully introduced awesome products into the retail market.
It will kick off investments later this year, in the range of $4-12m at Series A and Series B stage, offering investors a ten-year term and five-year investment period.